5-alpha-reductase inhibitors for lower urinary tract symptoms secondary to benign prostatic obstruction

Herney A. García-Perdomo; Hugo E. Lopez; James Tacklind

doi:10.1002/14651858.CD011928

5-alpha-reductase inhibitors for lower urinary tract symptoms secondary to benign prostatic obstruction

Herney A. García-Perdomo, Hugo E. Lopez, James Tacklind

Producción: Contribución a una revista › Artículo › revisión exhaustiva

1 Cita (Scopus)

Resumen

This is the protocol for a review and there is no abstract. The objectives are as follows: To assess the effects of 5-alpha-reductase inhibitors (5ARIs) for treating lower urinary tract symptoms (LUTS) secondary to benign prostatic obstruction (BPO).

Idioma original	Inglés
Número de artículo	CD011928
Publicación	Cochrane Database of Systematic Reviews
Volumen	2015
N.º	11
DOI	https://doi.org/10.1002/14651858.CD011928
Estado	Publicada - 04 nov. 2015
Publicado de forma externa	Sí

Acceder al documento

10.1002/14651858.CD011928

Otros archivos y enlaces

Enlace a la publicación en Scopus

Citar esto

@article{c15f0227d3e448af935412064f74dd24,

title = "5-alpha-reductase inhibitors for lower urinary tract symptoms secondary to benign prostatic obstruction",

abstract = "This is the protocol for a review and there is no abstract. The objectives are as follows: To assess the effects of 5-alpha-reductase inhibitors (5ARIs) for treating lower urinary tract symptoms (LUTS) secondary to benign prostatic obstruction (BPO).",

author = "Garc{\'i}a-Perdomo, {Herney A.} and Lopez, {Hugo E.} and James Tacklind",

note = "Publisher Copyright: {\textcopyright} 2015 The Cochrane Collaboration.",

year = "2015",

month = nov,

day = "4",

doi = "10.1002/14651858.CD011928",

language = "English",

volume = "2015",

journal = "Cochrane Database of Systematic Reviews",

issn = "1465-1858",

publisher = "John Wiley and Sons Ltd",

number = "11",

}

TY - JOUR

T1 - 5-alpha-reductase inhibitors for lower urinary tract symptoms secondary to benign prostatic obstruction

AU - García-Perdomo, Herney A.

AU - Lopez, Hugo E.

AU - Tacklind, James

PY - 2015/11/4

Y1 - 2015/11/4

N2 - This is the protocol for a review and there is no abstract. The objectives are as follows: To assess the effects of 5-alpha-reductase inhibitors (5ARIs) for treating lower urinary tract symptoms (LUTS) secondary to benign prostatic obstruction (BPO).

AB - This is the protocol for a review and there is no abstract. The objectives are as follows: To assess the effects of 5-alpha-reductase inhibitors (5ARIs) for treating lower urinary tract symptoms (LUTS) secondary to benign prostatic obstruction (BPO).

UR - http://www.scopus.com/inward/record.url?scp=85041748285&partnerID=8YFLogxK

U2 - 10.1002/14651858.CD011928

DO - 10.1002/14651858.CD011928

M3 - Article

AN - SCOPUS:85041748285

SN - 1465-1858

VL - 2015

JO - Cochrane Database of Systematic Reviews

JF - Cochrane Database of Systematic Reviews

IS - 11

M1 - CD011928

ER -

5-alpha-reductase inhibitors for lower urinary tract symptoms secondary to benign prostatic obstruction

Resumen

Acceder al documento

Otros archivos y enlaces

Huella

Citar esto